|
1
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng L, Yu X, Yu T, Xiao J and Huang Y:
Interventions for smoking cessation in people diagnosed with lung
cancer. Cochrane Database Syst Rev: CD011751. 2015. View Article : Google Scholar
|
|
3
|
Jahangeer S, Forde P, Soden D and Hinchion
J: Review of current thermal ablation treatment for lung cancer and
the potential of electrochemotherapy as a means for treatment of
lung tumours. Cancer Treat Rev. 39:862–871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai C, Shi R, Gao Y, Zeng J, Wei M, Wang
H, Zheng W and Ma W: Reduced expression of sushi domain containing
2 is associated with progression of non-small cell lung cancer.
Oncol Lett. 10:3619–3624. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SY, Jeon HM, Ju MK, Kim CH, Yoon G,
Han SI, Park HG and Kang HS: Wnt/Snail signaling regulates
cytochrome C oxidase and glucose metabolism. Cancer Res.
72:3607–3617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dupont C, Armant DR and Brenner CA:
Epigenetics: Definition, mechanisms and clinical perspective. Semin
Reprod Med. 27:351–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allen A: Epigenetic alterations and
cancer: New targets for therapy. IDrugs. 10:709–712.
2007.PubMed/NCBI
|
|
9
|
Bacigalupo ML, Manzi M, Espelt MV,
Gentilini LD, Compagno D, Laderach DJ, Wolfenstein-Todel C,
Rabinovich GA and Troncoso MF: Galectin-1 triggers
epithelial-mesenchymal transition in human hepatocellular carcinoma
cells. J Cell Physiol. 230:1298–1309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Xu Z, Li B, Zhang Z, Luo H, Wang Y,
Lu Z and Wu X: Epigenetic silencing of miRNA-9 is correlated with
promoter-proximal CpG island hypermethylation in gastric cancer
in vitro and in vivo. Int J Oncol. 45:2576–2586.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Licchesi JD, Westra WH, Hooker CM, Machida
EO, Baylin SB and Herman JG: Epigenetic alteration of Wnt pathway
antagonists in progressive glandular neoplasia of the lung.
Carcinogenesis. 29:895–904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ying J, Li H, Seng TJ, Langford C,
Srivastava G, Tsao SW, Putti T, Murray P, Chan AT and Tao Q:
Functional epigenetics identifies a protocadherin PCDH10 as a
candidate tumor suppressor for nasopharyngeal, esophageal and
multiple other carcinomas with frequent methylation. Oncogene.
25:1070–1080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hermann A, Gowher H and Jeltsch A:
Biochemistry and biology of mammalian DNA methyltransferases. Cell
Mol Life Sci. 61:2571–2587. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim H, Kwon YM, Kim JS, Han J, Shim YM,
Park J and Kim DH: Elevated mRNA levels of DNA methyltransferase-1
as an independent prognostic factor in primary nonsmall cell lung
cancer. Cancer. 107:1042–1049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kassis ES, Zhao M, Hong JA, Chen GA,
Nguyen DM and Schrump DS: Depletion of DNA methyltransferase 1
and/or DNA methyltransferase 3b mediates growth arrest and
apoptosis in lung and esophageal cancer and malignant pleural
mesothelioma cells. J Thorac Cardiovasc Surg. 131:298–306. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Belinsky SA, Klinge DM, Stidley CA, Issa
JP, Herman JG, March TH and Baylin SB: Inhibition of DNA
methylation and histone deacetylation prevents murine lung cancer.
Cancer Res. 63:7089–7093. 2003.PubMed/NCBI
|
|
17
|
Tan EJ, Kahata K, Idas O, Thuault S,
Heldin CH and Moustakas A: The high mobility group A2 protein
epigenetically silences the Cdh1 gene during
epithelial-to-mesenchymal transition. Nucleic Acids Res.
43:162–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Papageorgis P, Lambert AW, Ozturk S, Gao
F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM,
Lenburg M and Thiagalingam S: Smad signaling is required to
maintain epigenetic silencing during breast cancer progression.
Cancer Res. 70:968–978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin RK, Hsu CH and Wang YC: Mithramycin A
inhibits DNA methyltransferase and metastasis potential of lung
cancer cells. Anticancer Drugs. 18:1157–1164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Wang H, Gong L, Tang C and Yang H:
siRNAi targeted DNMT1 silence induces WIF-1 promoter
hypomethylation. Chongqing Med J. 40:1266–1268. 2011.(In
Chinese).
|
|
21
|
International symposium on lifestyle
factors and human lung cancer. Guangzhou, China, 12–16 December
1994. Proceedings and abstracts. Lung Cancer. 14 Suppl 1:S1–S245.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Q, Sun ZX, Allgayer H and Yang HS:
Downregulation of E-cadherin is an essential event in activating
beta-catenin/Tcf-dependent transcription and expression of its
target genes in Pdcd4 knockdown cells. Oncogene. 29:128–138. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hosono Y, Yamaguchi T, Mizutani E,
Yanagisawa K, Arima C, Tomida S, Shimada Y, Hiraoka M, Kato S,
Yokoi K, et al: MYBPH, a transcriptional target of TTF-1, inhibits
ROCK1, and reduces cell motility and metastasis. EMBO J.
31:481–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Zhu Y, Zhao M, Wu C, Zhang P, Tang
L, Zhang H, Chen X, Yang Y and Liu G: miRNA-29c suppresses lung
cancer cell adhesion to extracellular matrix and metastasis by
targeting integrin β1 and matrix metalloproteinase2 (MMP2). PLoS
One. 8:e701922013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chetty C, Lakka SS, Bhoopathi P and Rao
JS: MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated
PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer.
127:1081–1095. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rojiani MV, Alidina J, Esposito N and
Rojiani AM: Expression of MMP-2 correlates with increased
angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp
Pathol. 3:775–781. 2010.PubMed/NCBI
|
|
28
|
Zhou J, Xie M, Shi Y, Luo B, Gong G, Li J,
Wang J, Zhao W, Zi Y, Wu X and Wen J: MicroRNA-153 functions as a
tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer
cells. Oncol Rep. 34:111–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu Y, Zheng S, An N, Athanasopoulos T,
Popplewell L, Liang A, Li K, Hu C and Zhu Y: β-catenin as a
potential key target for tumor suppression. Int J Cancer.
129:1541–1551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oh SJ, Shin JH, Kim TH, Lee HS, Yoo JY,
Ahn JY, Broaddus RR, Taketo MM, Lydon JP, Leach RE, et al:
β-Catenin activation contributes to the pathogenesis of adenomyosis
through epithelial-mesenchymal transition. J Pathol. 231:210–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao JH, Luo Y, Jiang YG, He DL and Wu CT:
Knockdown of β-catenin through shRNA cause a reversal of EMT and
metastatic phenotypes induced by HIF-1α. Cancer Invest. 29:377–382.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Quan H, Zhou F, Nie D, Chen Q, Cai X, Shan
X, Zhou Z, Chen K, Huang A, Li S and Tang N: Hepatitis C virus core
protein epigenetically silences SFRP1 and enhances HCC
aggressiveness by inducing epithelial-mesenchymal transition.
Oncogene. 33:2826–2835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yee DS, Tang Y, Li X, Liu Z, Guo Y,
Ghaffar S, McQueen P, Atreya D, Xie J, Simoneau AR, et al: The Wnt
inhibitory factor 1 restoration in prostate cancer cells was
associated with reduced tumor growth, decreased capacity of cell
migration and invasion and a reversal of epithelial to mesenchymal
transition. Mol Cancer. 9:1622010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haslehurst AM, Koti M, Dharsee M, Nuin P,
Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, et al: EMT
transcription factors snail and slug directly contribute to
cisplatin resistance in ovarian cancer. BMC Cancer. 12:912012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Y, Min L, Zhang X, Hu S, Wang B, Liu
W, Wang R, Gu X, Shen W, Lv H, et al: Decreased miRNA-148a is
associated with lymph node metastasis and poor clinical outcomes
and functions as a suppressor of tumor metastasis in non-small cell
lung cancer. Oncol Rep. 30:1832–1840. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu
R, Pan Z, Kang T and Huang W: MicroRNA-342 inhibits colorectal
cancer cell proliferation and invasion by directly targeting DNA
methyltransferase 1. Carcinogenesis. 32:1033–1042. 2011. View Article : Google Scholar : PubMed/NCBI
|
